Novartis, Shire issue pink slips

Share this article:

Vivus is just one of a slate of companies that recently announced they were reducing workforce. The Boston Globe reports that Novartis has added 500 pink slips to that pile, pulling jobs from a research program in California, while at the same time opening 175 positions in Cambridge, MA. The Globe notes that Cambridge's gain somewhat offsets the recent announcement that Vertex was releasing employees, due to a hazardous HCV sales environment.

Shire is also cutting jobs. Reuters reports the specialty drugmaker is cutting around 180 R&D jobs at its Basingstoke, UK, office, where it has 520 people on-staff. The streamlining is part of the company's “One Shire” initiative.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.